International Journal Of Clinical Pharmacology And Therapeutics

International Journal Of Clinical Pharmacology And Therapeutics

国际临床药理学和治疗学杂志

  • 4区 中科院分区
  • Q4 JCR分区

期刊简介

《International Journal Of Clinical Pharmacology And Therapeutics》是由Dustri-Verlag Dr. Karl Feistle出版社于1994年创办的英文国际期刊(ISSN: 0946-1965,E-ISSN: 0946-1965),该期刊长期致力于药学领域的创新研究,主要研究方向为医学-药学。作为SCIE收录期刊(JCR分区 Q4,中科院 4区),本刊采用OA未开放获取模式(OA占比0%),以发表药学领域等方向的原创性研究为核心(研究类文章占比93.83%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在81篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

International Journal Of Clinical Pharmacology And Therapeutics审稿周期约为 偏慢,4-8周 。该刊近年未被列入国际预警名单,年发文量约81篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 81 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q4 309 / 354

12.9%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q4 298 / 354

15.96%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:1.7 SJR:0.261 SNIP:0.294
学科类别 分区 排名 百分位
大类:Medicine 小类:Pharmacology (medical) Q3 186 / 272

31%

大类:Medicine 小类:Pharmacology Q3 235 / 313

25%

期刊发文

  • Efficacy and safety of belimumab in lupus nephritis: A retrospective study

    Author: Zhang, Zhaowei; Chen, Jiayin; Du, Hongwei; Hua, Li

    Journal: INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2023; Vol. 61, Issue 5, pp. 196-203. DOI: 10.5414/CP204323

  • Changes in the intestinal microbiota of patients with Parkinson's disease and their clinical significance

    Author: Zhang, Li-Na; Yuan, Wen -Ling; Ye, Ming; Yin, Liang; Wang, Shi-Jie

    Journal: INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2023; Vol. 61, Issue 2, pp. 48-58. DOI: 10.5414/CP204285

  • Application of low-dose etomidate combined with oxycodone and midazolam in endoscopic injection sclerotherapy

    Author: Yao, Jie; Hao, Shuai; Zhou, Chen; Cao, YingHao; Quan, ZheFeng

    Journal: INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2023; Vol. 61, Issue 3, pp. 122-128. DOI: 10.5414/CP204341

  • Pharmacokinetics, safety, and bioequivalence of apixaban tablets in healthy Chinese subjects under fasting and fed conditions

    Author: Luo, Hong-Yu; Yao, Zhen-Jiang; Long, Hui-Zhi; Zhou, Zi-Wei; Xu, Shuo-Guo; Li, Feng-Jiao; Cheng, Yan; Wen, Dan -Dan; Deng, Ping; Guan, Yue-Qing; Gao, Li-Chen

    Journal: INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2023; Vol. 61, Issue 3, pp. 129-138. DOI: 10.5414/CP204299

  • A pharmacokinetic analysis of amisulpride in adult Chinese patients with schizophrenia: Impact of creatinine clearance

    Author: Liu, Wei; Zhou, Jingqi; Cao, Minjuan; Zhang, Fangming; Sun, Xiaoming

    Journal: INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2023; Vol. 61, Issue 5, pp. 204-213. DOI: 10.5414/CP204334

  • Analgesia with reduced incidence of adverse reactions using flurbiprofen axetil in combination with half standard-dose opioids in primary total knee arthroplasty

    Author: Xiao, Jiecheng; Zhao, Chengfei; Zhu, Junteng; Lin, Qi; Shen, Jianlin; Liu, Jie; Cai, Hanhua; Wu, Xianwei

    Journal: INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2023; Vol. , Issue , pp. -. DOI: 10.5414/CP204319

  • Bioequivalence study of domperidone dry suspension in healthy Chinese subjects under fasted and fed conditions: An open-label, randomized, single-dose, crossover trial

    Author: Wu, Lihua; Huang, Qian; Lin, Meihua; Kai, Jiejing; Huang, Yujie; Zhai, You; Liu, Jian; Shentu, Jianzhong

    Journal: INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2023; Vol. , Issue , pp. -. DOI: 10.5414/CP204309

  • Pharmacokinetic and bioequivalence of lenalidomide in multiple myeloma patients

    Author: Shen, Qi; Gao, Tiantao; Xiang, Jin; Feng, Ping; Liu, Xinghong; Zheng, Li

    Journal: INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2023; Vol. 61, Issue 4, pp. 181-188. DOI: 10.5414/CP204224